Osimertinib 13C D3
| Product Name | Osimertinib 13C D3 |
|---|---|
| CAT No. | CS-AI-00164 |
| CAS No. | 1421373-65-0(Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 503.62 g/mol |
| Mol. For. | C₂₇¹³CH₃₀D₃N₇O₂ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Purity | 95% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | CN1C=C(C2=NC(NC(C=C(NC(C=C)=O)C(N(C([2H])([2H])[2H])CCN(C)C)=C3)=C3OC)=NC=C2)C4=CC=CC=C14 |
| Canonical Smiles | CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC |
| InchIKey | DUYJMQONPNNFPI-UHFFFAOYSA-N |
| Inchl | InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32) |
| IUPAC | N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Osimertinib 13C D3 is a stable isotope-labeled version of osimertinib, a medication used in the treatment of non-small cell lung cancer (NSCLC) that has a specific mutation called EGFR T790M. Osimertinib 13C D3 is used as an internal standard in analytical applications such as liquid chromatography-mass spectrometry (LC-MS) to accurately quantify the concentration of osimertinib in biological samples.
The chemical structure of osimertinib 13C D3 is nearly identical to osimertinib, but contains three carbon-13 isotopes in the pyrimidine ring. Osimertinib 13C D3 has a molecular weight of 505.43 g/mol, compared to osimertinib's molecular weight of 499.44 g/mol. The isotopic labeling of osimertinib 13C D3 does not affect its pharmacological properties or efficacy in treating NSCLC.
Osimertinib works by inhibiting the activity of the mutated EGFR protein, which is responsible for the growth and proliferation of cancer cells. By blocking this activity, osimertinib can slow down or stop the growth of NSCLC tumors. Osimertinib is typically administered orally once a day, with or without food.
In conclusion, osimertinib 13C D3 is a useful tool for accurately measuring the concentration of osimertinib in biological samples. Its isotopic labeling does not affect its pharmacological properties or efficacy in treating NSCLC.
Get an Instant Quote
This page contains information about Osimertinib 13C D3. You can buy Osimertinib 13C D3 from Clearsynth at best competitive price with assured price guarantee. Clearsynth offers best quality Osimertinib 13C D3